Literature DB >> 16973807

Subclinical left ventricular dysfunction in normotensive women with Turner's syndrome.

N H Andersen, B E Hjerrild, K Sørensen, E M Pedersen, K Stochholm, L C Gormsen, A Hørlyck, J S Christiansen, C H Gravholt.   

Abstract

Entities:  

Mesh:

Year:  2006        PMID: 16973807      PMCID: PMC1861017          DOI: 10.1136/hrt.2005.081471

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  5 in total

1.  A comparison of echocardiography and magnetic resonance imaging in cardiovascular screening of adults with Turner syndrome.

Authors:  Julia E Ostberg; Jocelyn A S Brookes; Carolyn McCarthy; Julian Halcox; Gerard S Conway
Journal:  J Clin Endocrinol Metab       Date:  2004-12       Impact factor: 5.958

2.  Nocturnal hypertension and impaired sympathovagal tone in Turner syndrome.

Authors:  Claus Højbjerg Gravholt; Klavs Würgler Hansen; Mogens Erlandsen; Eva Ebbehøj; Jens Sandahl Christiansen
Journal:  J Hypertens       Date:  2006-02       Impact factor: 4.844

3.  Morbidity in Turner syndrome.

Authors:  C H Gravholt; S Juul; R W Naeraa; J Hansen
Journal:  J Clin Epidemiol       Date:  1998-02       Impact factor: 6.437

4.  The effect of hormone replacement therapy on cardiovascular hemodynamics in women with Turner's syndrome.

Authors:  M Elsheikh; R Bird; B Casadei; G S Conway; J A Wass
Journal:  J Clin Endocrinol Metab       Date:  2000-02       Impact factor: 5.958

5.  Left ventricular dysfunction in hypertensive patients with Type 2 diabetes mellitus.

Authors:  N H Andersen; S H Poulsen; P L Poulsen; S T Knudsen; K Helleberg; K W Hansen; T J Berg; A Flyvbjerg; C E Mogensen
Journal:  Diabet Med       Date:  2005-09       Impact factor: 4.359

  5 in total
  7 in total

Review 1.  Turner syndrome.

Authors:  Shelli R Kesler
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2007-07

Review 2.  Hypertension in Children and Adolescents with Turner Syndrome (TS), Neurofibromatosis 1 (NF1), and Williams Syndrome (WS).

Authors:  Ramya Sivasubramanian; Kevin E Meyers
Journal:  Curr Hypertens Rep       Date:  2021-03-29       Impact factor: 5.369

3.  Growth hormone treatment and left ventricular dimensions in Turner syndrome.

Authors:  Lea Ann Matura; Vandana Sachdev; Vladimir K Bakalov; Douglas R Rosing; Carolyn A Bondy
Journal:  J Pediatr       Date:  2007-06       Impact factor: 4.406

4.  Two-dimensional speckle tracking of the abdominal aorta: a novel approach to evaluate arterial stiffness in patients with Turner syndrome.

Authors:  Felix Sebastian Oberhoffer; Hashim Abdul-Khaliq; Anna-Maria Jung; Tilman R Rohrer; Mohamed Abd El Rahman
Journal:  Cardiovasc Diagn Ther       Date:  2019-10

5.  Blunting of cardioprotective actions of estrogen in female rodent heart linked to altered expression of cardiac tissue chymase and ACE2.

Authors:  Jacqueline S da Silva; Daniele Gabriel-Costa; Hao Wang; Sarfaraz Ahmad; Xuming Sun; Jasmina Varagic; Roberto T Sudo; Carlos M Ferrario; Louis J Dell Italia; Gisele-Zapata Sudo; Leanne Groban
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2017 Jul-Sep       Impact factor: 1.636

6.  Impaired aortic distensibility and elevated central blood pressure in Turner Syndrome: a cardiovascular magnetic resonance study.

Authors:  Jan Wen; Christian Trolle; Mette H Viuff; Steffen Ringgaard; Esben Laugesen; Ephraim J Gutmark; Dhananjay Radhakrishnan Subramaniam; Philippe Backeljauw; Iris Gutmark-Little; Niels H Andersen; Kristian H Mortensen; Claus H Gravholt
Journal:  J Cardiovasc Magn Reson       Date:  2018-12-13       Impact factor: 5.364

7.  Assessment of left ventricular myocardial work in Turner syndrome patients: insights from the novel non-invasive pressure-strain loop analysis method.

Authors:  Felix Sebastian Oberhoffer; Hashim Abdul-Khaliq; Anna-Maria Jung; Michael Zemlin; Tilman R Rohrer; Mohamed Abd El Rahman
Journal:  Quant Imaging Med Surg       Date:  2020-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.